Edarbi vs. Terazosin hydrochloride

Summary

We compare the side effects and drug effectiveness of Edarbi and Terazosin hydrochloride. The study is created by eHealthMe based on reports of 18,293 people who take Edarbi and Terazosin hydrochloride, and is updated regularly.



What's eHealthMe?

eHealthMe is a health data analysis company based in Mountain View, California. eHealthMe monitors and analyzes the outcomes of drugs and supplements that are currently on the market. The results are readily available to health care professionals and consumers.

eHealthMe has released original studies on market drugs and worked with leading universities and institutions such as IBM, London Health Science Centre, Mayo Clinic, Northwestern University and VA. eHealthMe studies have now been referenced in over 500 peer-reviewed medical publications.

How we gather our data?

Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference.

The information that eHealthMe collects includes:

  • Side effects (including severity and how people recover from them)
  • Associated conditions or symptoms
  • Drug effectiveness
  • Demographic data regarding drug use

How the study uses the data?

The study is based on azilsartan medoxomil and terazosin hydrochloride (the active ingredients of Edarbi and Terazosin hydrochloride, respectively), and Edarbi and Terazosin hydrochloride (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

What is Edarbi?

Edarbi has active ingredients of azilsartan medoxomil. It is often used in high blood pressure. (latest outcomes from Edarbi 366 users)

What is Terazosin hydrochloride?

Terazosin hydrochloride has active ingredients of terazosin hydrochloride. It is often used in prostate examination abnormal. (latest outcomes from Terazosin hydrochloride 1,678 users)

How to use the study?

Patients can bring a copy of the report to their healthcare provider to ensure that all drug risks and benefits are fully discussed and understood. It is recommended that patients use the information presented as a part of a broader decision-making process.


On Mar, 17, 2019

18,293 people who take Edarbi and Terazosin hydrochloride are studied.


Number of reports submitted per year:

Edarbi vs Terazosin hydrochloride drug comparison reports.

Drugs in this study:

  • Terazosin Hydrochloride (terazosin hydrochloride)
  • Edarbi (azilsartan medoxomil)

eHealthMe real world results:

Most common side effects:

Edarbi:
  1. Drug Ineffective
  2. Dyspnoea (difficult or laboured respiration)
  3. Dizziness
  4. Fatigue (feeling of tiredness)
  5. Diarrhoea
  6. Nausea (feeling of having an urge to vomit)
  7. Asthenia (weakness)
  8. Hypotension (abnormally low blood pressure)
  9. Pain
  10. Fall
Terazosin Hydrochloride:
  1. Dizziness
  2. Nausea (feeling of having an urge to vomit)
  3. Drug Ineffective
  4. Hypotension (abnormally low blood pressure)
  5. Diarrhoea
  6. Renal Impairment (severely reduced kidney function)
  7. Fatigue (feeling of tiredness)
  8. Fall
  9. Headache (pain in head)
  10. Blood Pressure Decreased

Most common side effects experienced by people in long term use:

Edarbi:
  1. Syncope (loss of consciousness with an inability to maintain postural tone)
  2. Hypotension (abnormally low blood pressure)
  3. Dizziness
  4. Orthostatic Hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up)
  5. Fall
  6. Dyspnoea (difficult or laboured respiration)
  7. Asthenia (weakness)
  8. Myocardial Infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  9. Bradycardia (abnormally slow heart action)
  10. Loss Of Consciousness
Terazosin Hydrochloride:
  1. Pneumonia
  2. Cerebral Infarction (less blood supply to brain resulting tissue damage)
  3. Respiratory Arrest (cessation of normal respiration due to failure of the lungs to function effectively)
  4. Gingival Bleeding (bleeding gums)
  5. Cardiac Arrest
  6. Haemorrhagic Cerebral Infarction (brain stroke with bleeding)
  7. Embolic Cerebral Infarction (brain stroke due to obstruction of an artery)
  8. Inguinal Hernia (hernia in which a loop of intestine enters the inguinal canal; the most common type of hernia in males)
  9. Vitamin D
  10. Dyspnoea (difficult or laboured respiration)

Drug effectiveness:

Edarbi:
  • not at all: 2.47 %
  • somewhat: 24.45 %
  • moderate: 38.46 %
  • high: 27.47 %
  • very high: 7.14 %
Terazosin Hydrochloride:
  • not at all: 0 %
  • somewhat: 17.24 %
  • moderate: 34.48 %
  • high: 37.93 %
  • very high: 10.34 %

Do you take Edarbi or Terazosin hydrochloride?

You are not alone:




Related studies:



Recent updates

Recent general studies
Recent personal studies


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Submit your testimonial

  • Please fill in your Testimonial.
  • Please enter a minimum of 10 characters for your Testimonial.
  • Please fill in your Name.

Please wait...

{progressItem}

Thank you!